COMP <GO>
CTMX vs ARVN // NET PROFIT MARGIN
CytomX Therapeutics Inc. (NASDAQ) VS. Arvinas Inc. (NASDAQ) • 15-METRIC TALLY: CTMX 3
— ARVN 4
▲ NET PROFIT MARGIN LEADER: CTMX
LAST: $2.34 (+2.18%) • MKT CAP: $509.9M
net-margins
-22.80%
LAST: $7.86 (-0.51%) • MKT CAP: $513.9M
net-margins
-30.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTMX VS. ARVN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTMX | ARVN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -20.50% | -32.10% | +11.60 | CTMX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.19% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -29.30% | -45.10% | +15.80 | CTMX | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -22.80% | -30.80% | +8.00 | CTMX | /net-margins <GO> |
| Revenue Growth (YoY) | -44.80% | -0.30% | -44.50 | ARVN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 3/9 | -2.00 | ARVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.5 | 54.4 | -10.90 | ARVN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $509.9M | $513.9M | -$4.1M | ARVN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTMX REV | ARVN REV | CTMX GROSS % | ARVN GROSS % | CTMX FCF | ARVN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $76.2M | $262.6M | — | — | -$75.8M | -$275.7M |
| FY 2024 | $138.1M | $263.4M | — | — | -$86.5M | -$261.1M |
| FY 2023 | $101.2M | $78.5M | — | — | -$56.0M | -$347.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTMX // BETA —
ARVN // BETA —